In a recent article for Pharmiweb, Amplexor’s David Gwyn weighs in on the ways in which pharmaceutical companies can maximize their use of digital solutions.
Having digitalised and centralised all of its regulated product data, a major global pharmaceutical company recently realised that it now has unprecedented insight into the relative regulatory and market status of all of its products right across the world.
With more than 25 years of experience in the Life Sciences industry, David Gwyn is a seasoned executive with extensive experience delivering solutions to clients, with a particular focus in the areas of content management and collaboration. As a Vice President for AMPLEXOR Life Sciences, David’s main focus is aligning customer needs with the capabilities of the company’s Life Sciences Suite to ensure that the solution meets the needs of the customer. David also leads the DIA EDM Submission Reference Model team, which has developed a document architecture for use when designing and building content management solutions. This architecture has been leveraged by numerous companies and vendors to provide submission management solutions that are compliant with global regulations.